TrialDiabetes, obesity & metabolism2022

Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin-R with the US-licensed Humulin® R formulation in healthy subjects: Results from the RHINE-1 (Recombinant Human INsulin Equivalence-1) study.

Leona Plum-Mörschel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.